SRx Health Solutions Inc.
SRXH
$0.14
$0.017.51%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 108.12% | -401.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 108.12% | -401.81% | |||
| Cost of Revenue | 106.80% | -421.10% | |||
| Gross Profit | 112.02% | -356.51% | |||
| SG&A Expenses | 118.04% | -247.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 112.53% | -301.04% | |||
| Operating Income | -120.96% | 222.73% | |||
| Income Before Tax | -139.61% | 230.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -140.81% | 239.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 43.56% | -0.85% | |||
| EBIT | -120.96% | 222.73% | |||
| EBITDA | -124.82% | 210.51% | |||
| EPS Basic | 57.01% | 19.94% | |||
| Normalized Basic EPS | -114.23% | 250.18% | |||
| EPS Diluted | 56.10% | 20.15% | |||
| Normalized Diluted EPS | -114.23% | 250.18% | |||
| Average Basic Shares Outstanding | 59.84% | 3.46% | |||
| Average Diluted Shares Outstanding | 59.84% | 3.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||